Ethyl [2,2':6',2''-terpyridine]-4'-carboxylate, 98%, 1g

1,3-Dibromo-2-difluoromethoxy-benzene, 95+%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(1-(tert-butoxycarbonyl)-1H-indol-3-yl)propanoic acid, 98%, 5g

Norlaudanosine Hydrochloride>98.0%(HPLC)(N)25g

4-(4-tert-Butylphenoxy)benzaldehyde, 1g

ETHYL (E)-3-(6-AMINOPYRIDIN-3-YL)ACRYLATE, 95%, 1g

(S)-1-((1S,3aR,4S,7aR)-4-((tert-Butyldimethylsilyl)oxy)-7a-methyloctahydro-1H-inden-1-yl)ethan-1-ol, 98%, 100mg

(2S,3S)-2-BENZYL-3-(TERT-BUTYL)-4-(2,6-DIMETHOXYPHENYL)-2,3-DIHYDROBENZO[D][1,3]OXAPHOSPHOLE, 95%, 500mg

2-Benzylpyridine>98.0%(GC)(T)25mL

4-Chloro-2-(piperazin-1-yl)pyrimidine hydrochloride, 95.0%, 500mg

Pyrazinecarboxylic Acid>98.0%(HPLC)(T)500g

7-Chloro-2-methyl-1H-pyrrolo[2,3-c]pyridine, 95.0%, 1g

N-(4-BROMOPHENYL)-4-METHOXYBENZAMIDE, 95.0%, 1g